Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Discovery of Novel Spiro[3H-indole-3,2′-pyrrolidin]-2(1H)-one Compounds as Chemically Stable and Orally Active Inhibitors of the MDM2–p53 Interaction
Andreas Gollner, Dorothea Rudolph, Heribert Arnhof, et al.
Journal of Medicinal Chemistry (2016) Vol. 59, Iss. 22, pp. 10147-10162
Closed Access | Times Cited: 107

Showing 1-25 of 107 citing articles:

Stereoselective synthesis and applications of spirocyclic oxindoles
Alexander J. Boddy, James A. Bull
Organic Chemistry Frontiers (2021) Vol. 8, Iss. 5, pp. 1026-1084
Open Access | Times Cited: 251
Protein posttranslational modifications in health and diseases: Functions, regulatory mechanisms, and therapeutic implications
Qian Zhong, Xina Xiao, Yijie Qiu, et al.
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 114
MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future
Wei Wang, Najah Albadari, Yi Du, et al.
Pharmacological Reviews (2024) Vol. 76, Iss. 3, pp. 414-453
Open Access | Times Cited: 31
From Discovery to Bedside: Targeting the Ubiquitin System
Ingrid E. Wertz, Xiao‐Jing Wang
Cell chemical biology (2018) Vol. 26, Iss. 2, pp. 156-177
Open Access | Times Cited: 131
Synthesis of new thiazolo-pyrrolidine–(spirooxindole) tethered to 3-acylindole as anticancer agents
Mohammad Shahidul Islam, Hussien Mansur Ghawas, Fardous F. El‐Senduny, et al.
Bioorganic Chemistry (2018) Vol. 82, pp. 423-430
Closed Access | Times Cited: 85
Anticancer potential of spirocompounds in medicinal chemistry: A pentennial expedition
Darshana Bora, Anjali Kaushal, Nagula Shankaraiah
European Journal of Medicinal Chemistry (2021) Vol. 215, pp. 113263-113263
Closed Access | Times Cited: 79
2-Oxindole and related heterocycles: synthetic methodologies for their natural products and related derivatives
Shivangi Sharma, Yukti Monga, Ashu Gupta, et al.
RSC Advances (2023) Vol. 13, Iss. 21, pp. 14249-14267
Open Access | Times Cited: 32
Design and synthesis of new substituted spirooxindoles as potential inhibitors of the MDM2–p53 interaction
Assem Barakat, Mohammad Shahidul Islam, Hussien Mansur Ghawas, et al.
Bioorganic Chemistry (2019) Vol. 86, pp. 598-608
Closed Access | Times Cited: 73
Role of p53 circuitry in tumorigenesis: A brief review
Sarfaraj Niazi, Madhusudan Purohit, Javed H. Niazi
European Journal of Medicinal Chemistry (2018) Vol. 158, pp. 7-24
Closed Access | Times Cited: 61
Synthesis, and evaluation of in vitro and in vivo anticancer activity of 14-substituted oridonin analogs: A novel and potent cell cycle arrest and apoptosis inducer through the p53-MDM2 pathway
Qing‐Kun Shen, Hao Deng, Shi-Ben Wang, et al.
European Journal of Medicinal Chemistry (2019) Vol. 173, pp. 15-31
Closed Access | Times Cited: 58
Design, synthesis, and biological evaluation of nitroisoxazole-containing spiro[pyrrolidin-oxindole] derivatives as novel glutathione peroxidase 4/mouse double minute 2 dual inhibitors that inhibit breast adenocarcinoma cell proliferation
Shuai‐Jiang Liu, Qian Zhao, Cheng Peng, et al.
European Journal of Medicinal Chemistry (2021) Vol. 217, pp. 113359-113359
Closed Access | Times Cited: 47
Molecular hybridization design and synthesis of novel spirooxindole-based MDM2 inhibitors endowed with BCL2 signaling attenuation; a step towards the next generation p53 activators
Gehad Lotfy, Yasmine M. Abdel Aziz, Mohamed M. Said, et al.
Bioorganic Chemistry (2021) Vol. 117, pp. 105427-105427
Open Access | Times Cited: 44
Decoding the messaging of the ubiquitin system using chemical and protein probes
Lukas T. Henneberg, Brenda A. Schulman
Cell chemical biology (2021) Vol. 28, Iss. 7, pp. 889-902
Open Access | Times Cited: 41
Recent advances in the (3+2) cycloaddition of azomethine ylide
Sapana Dubey, Anit Pal, S. R. Roy, et al.
New Journal of Chemistry (2023) Vol. 47, Iss. 19, pp. 8997-9034
Closed Access | Times Cited: 21
Optimized spirooxindole-pyrazole hybrids targeting the p53-MDM2 interplay induce apoptosis and synergize with doxorubicin in A549 cells
Mohammad Shahidul Islam, Abdullah Mohammed Al‐Majid, Essam Nageh Sholkamy, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 16
A balancing act: using small molecules for therapeutic intervention of the p53 pathway in cancer
Jessica J. Miller, Christian Gaiddon, Tim Storr
Chemical Society Reviews (2020) Vol. 49, Iss. 19, pp. 6995-7014
Closed Access | Times Cited: 42
Recent Small-Molecule Inhibitors of the p53–MDM2 Protein–Protein Interaction
Anastasia A. Beloglazkina, N. V. Zyk, Alexander G. Majouga, et al.
Molecules (2020) Vol. 25, Iss. 5, pp. 1211-1211
Open Access | Times Cited: 41
Nanoformulation of Spirooxindole and Methods for Treating Hepatocellular Carcinoma
Assem Barakat, Fardous F. El‐Senduny, Mohammad Shahidul Islam, et al.
Pharmaceutics (2025) Vol. 17, Iss. 1, pp. 93-93
Open Access
The Therapeutic Potential of Spirooxindoles in Cancer: A Focus on p53–MDM2 Modulation
Adel S. Girgis, Yujun Zhao, Angel Nkosi, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 2, pp. 274-274
Open Access
Small glycomimetic antagonists of the cytomegalovirus glycoprotein UL141 prevent binding to TRAIL death receptor
Ivana Nemčovičová, Juraj Kóňa, Monika Poláková, et al.
Journal of Biological Chemistry (2025), pp. 108490-108490
Open Access
Regio- and stereoselective synthesis of new spirooxindoles via 1,3-dipolar cycloaddition reaction: Anticancer and molecular docking studies
Gehad Lotfy, El Sayed H. El Ashry, Mohamed M. Said, et al.
Journal of Photochemistry and Photobiology B Biology (2018) Vol. 180, pp. 98-108
Closed Access | Times Cited: 45
An integrated in silico screening strategy for identifying promising disruptors of p53-MDM2 interaction
Hajar Sirous, Giulia Chemi, Giuseppe Campiani, et al.
Computational Biology and Chemistry (2019) Vol. 83, pp. 107105-107105
Closed Access | Times Cited: 42
Microwave‐Assisted One‐Pot [3+2] Cycloaddition of Azomethine Ylides and 3‐Alkenyl Oxindoles: A Facile Approach to Pyrrolidine‐Fused Bis‐Spirooxindoles
Sonal Bhandari, Sravani Sana, Balasubramanyam Sridhar, et al.
ChemistrySelect (2019) Vol. 4, Iss. 5, pp. 1727-1730
Closed Access | Times Cited: 35
Design, Synthesis, Chemical and Biochemical Insights Into Novel Hybrid Spirooxindole-Based p53-MDM2 Inhibitors With Potential Bcl2 Signaling Attenuation
Yasmine M. Abdel Aziz, Gehad Lotfy, Mohamed M. Said, et al.
Frontiers in Chemistry (2021) Vol. 9
Open Access | Times Cited: 32
Microwave-assisted rapid synthesis of spirooxindole-pyrrolizidine analogues and their activity as anti-amyloidogenic agents
Nilamuni H. de Silva, Suneela Pyreddy, Ewan W. Blanch, et al.
Bioorganic Chemistry (2021) Vol. 114, pp. 105128-105128
Closed Access | Times Cited: 28
Page 1 - Next Page

Scroll to top